Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
L Pagano, CG Valentini, S Grammatico… - British journal of …, 2016 - Wiley Online Library
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
N Pemmaraju, M Konopleva - Blood advances, 2020 - Elsevier
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and clinically challenging
hematologic malignancy with dismal outcomes. With a median age of∼ 70 years, the …
hematologic malignancy with dismal outcomes. With a median age of∼ 70 years, the …
[HTML][HTML] Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm
N Pemmaraju, AA Lane, KL Sweet… - … England Journal of …, 2019 - Mass Medical Soc
Background Blastic plasmacytoid dendritic-cell neoplasm (BPDCN) is an aggressive
hematologic cancer that is caused by transformed plasmacytoid dendritic cells that …
hematologic cancer that is caused by transformed plasmacytoid dendritic cells that …
Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology
DA Pollyea, JK Altman, R Assi, D Bixby… - Journal of the National …, 2023 - jnccn.org
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized
by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other …
by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other …
[HTML][HTML] Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
F Julia, T Petrella, M Beylot‐Barry… - British Journal of …, 2013 - academic.oup.com
Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J Menezes, F Acquadro, M Wiseman, G Gómez-López… - Leukemia, 2014 - nature.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare disease that currently
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
T Aoki, R Suzuki, Y Kuwatsuka, S Kako… - Blood, The Journal …, 2015 - ashpublications.org
We sought to clarify the role of high-dose chemotherapy followed by autologous
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
N Pemmaraju, H Kantarjian, K Sweet, E Wang… - Blood, 2023 - ashpublications.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood …
D Roos-Weil, S Dietrich, A Boumendil… - Blood, The Journal …, 2013 - ashpublications.org
Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have a poor prognosis
with conventional chemotherapy. In the present study, we retrospectively analyzed the …
with conventional chemotherapy. In the present study, we retrospectively analyzed the …